Efficacy of antiviral drugs against the omicron variant of SARS-CoV-2.
A. Dabrowska, A. Szczepanski, P. Botwina, N. Mazur-Panasiuk, H. Jirincova, L. Rabalski, T. Zajic, G. Popowicz, K. Pyrc
This study evaluates the efficacy of antivirals against SARS-CoV-2 variants, including Omicron, Delta, and the early 2020 isolate.
bioRxiv · Dec 21, 2021 · PreprintMicrobiology